1187: Oliver RT. Circumcision and/or vaccination against human papillomavirus in 
the male to prevent infection with human immunodeficiency virus: an early
surrogate endpoint for the later prevention of penile, prostate, anal and oral
cancer? BJU Int. 2009 Sep;104(6):753-5. doi: 10.1111/j.1464-410X.2009.08596.x.
Epub 2009 May 7. PubMed PMID: 19426185.


1188: Oliver RT, Williams G, Paris AM, Blandy JP. Intermittent androgen
deprivation after PSA-complete response as a strategy to reduce induction of
hormone-resistant prostate cancer. Urology. 1997 Jan;49(1):79-82. PubMed PMID:
9000190.


1189: Oliver RT. New directions with hormone therapy in prostate cancer: possible
benefit from blocking prolactin and use of hormone treatment intermittently in
combination with immunotherapy. Eur J Cancer. 1995 Jun;31A(6):859-60. PubMed
PMID: 7646910.


1190: Oliver RT, Gallagher CJ. Intermittent endocrine therapy and its potential
for chemoprevention of prostate cancer. Cancer Surv. 1995;23:191-207. Review.
PubMed PMID: 7621458.


1191: Oliver RT, Joseph JV, Gallagher CJ. Castration-induced lymphocytosis in
prostate cancer: possible evidence for gonad/thymus endocrine interaction in man.
Urol Int. 1995;54(4):226-9. PubMed PMID: 7610506.